GENLISA Human Centrosomal Colon Cancer Autoantigen Protein (CCCAP) ELISA

The GENLISA Human Centrosomal Colon Cancer Autoantigen Protein (CCCAP) ELISA includes features like: - Ready to use protocol with break-apart wells for ease of use - Standardisation and High Reproducibility - Lot to Lot Consistency - Accuracy and Precision Validated against seven points for a “GOLD RING” Standard Quality ELISA - the benchmark sign for Krishgen Quality. The The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be human serum, plasma, biological fluids and cell culture supernatant. The kit uses indirect sandwich assay with double antibodies - capture and detection to ensure a high degree of sensitivity and specificity in the estimation of Centrosomal Colon Cancer Autoantigen Protein (CCCAP)